CDC7_HUMAN - dbPTM
CDC7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDC7_HUMAN
UniProt AC O00311
Protein Name Cell division cycle 7-related protein kinase
Gene Name CDC7
Organism Homo sapiens (Human).
Sequence Length 574
Subcellular Localization Nucleus.
Protein Description Seems to phosphorylate critical substrates that regulate the G1/S phase transition and/or DNA replication. Can phosphorylates MCM2 and MCM3..
Protein Sequence MEASLGIQMDEPMAFSPQRDRFQAEGSLKKNEQNFKLAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKSHIITGNKIPLSGPVPKELDQQSTTKASVKRPYTNAQIQIKQGKDGKEGSVGLSVQRSVFGERNFNIHSSISHESPAVKLMKQSKTVDVLSRKLATKKKAISTKVMNSAVMRKTASSCPASLTCDCYATDKVCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHASHQPAISEKTDHKASCLVQTPPGQYSGNSFKKGDSNSCEHCFDEYNTNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEASLGIQMDE
----CCCCCCCCCCC
17.5226074081
16PhosphorylationMDEPMAFSPQRDRFQ
CCCCCCCCCCHHHHH
15.5817192257
27PhosphorylationDRFQAEGSLKKNEQN
HHHHHHCCCHHCHHC
28.6425159151
29UbiquitinationFQAEGSLKKNEQNFK
HHHHCCCHHCHHCCE
56.07-
30UbiquitinationQAEGSLKKNEQNFKL
HHHCCCHHCHHCCEE
71.64-
36SumoylationKKNEQNFKLAGVKKD
HHCHHCCEECCHHHH
45.00-
36SumoylationKKNEQNFKLAGVKKD
HHCHHCCEECCHHHH
45.00-
36UbiquitinationKKNEQNFKLAGVKKD
HHCHHCCEECCHHHH
45.00-
48PhosphorylationKKDIEKLYEAVPQLS
HHHHHHHHHHHHHHH
16.9527642862
59SumoylationPQLSNVFKIEDKIGE
HHHHCCEEEECCCCC
40.69-
59SumoylationPQLSNVFKIEDKIGE
HHHHCCEEEECCCCC
40.69-
59UbiquitinationPQLSNVFKIEDKIGE
HHHHCCEEEECCCCC
40.69-
90UbiquitinationPEEKIALKHLIPTSH
CHHHHHHHHHCCCCC
27.61-
179UbiquitinationGIVHRDVKPSNFLYN
CCCCCCCCCHHHCCC
47.20-
179SumoylationGIVHRDVKPSNFLYN
CCCCCCCCCHHHCCC
47.20-
179SumoylationGIVHRDVKPSNFLYN
CCCCCCCCCHHHCCC
47.20-
181PhosphorylationVHRDVKPSNFLYNRR
CCCCCCCHHHCCCCC
34.2019664994
191UbiquitinationLYNRRLKKYALVDFG
CCCCCCCEEEEECCC
40.11-
192PhosphorylationYNRRLKKYALVDFGL
CCCCCCEEEEECCCC
11.9929496907
207UbiquitinationAQGTHDTKIELLKFV
CCCCCHHHHHHHHHH
39.99-
212UbiquitinationDTKIELLKFVQSEAQ
HHHHHHHHHHHHHHH
56.992190698
216PhosphorylationELLKFVQSEAQQERC
HHHHHHHHHHHHHHH
29.60-
227UbiquitinationQERCSQNKSHIITGN
HHHHHCCCCCEECCC
35.46-
235SumoylationSHIITGNKIPLSGPV
CCEECCCCCCCCCCC
47.23-
235SumoylationSHIITGNKIPLSGPV
CCEECCCCCCCCCCC
47.23-
235UbiquitinationSHIITGNKIPLSGPV
CCEECCCCCCCCCCC
47.23-
239PhosphorylationTGNKIPLSGPVPKEL
CCCCCCCCCCCCCCC
35.3823312004
244SumoylationPLSGPVPKELDQQST
CCCCCCCCCCCCCCC
71.75-
244SumoylationPLSGPVPKELDQQST
CCCCCCCCCCCCCCC
71.75-
244UbiquitinationPLSGPVPKELDQQST
CCCCCCCCCCCCCCC
71.75-
253UbiquitinationLDQQSTTKASVKRPY
CCCCCCCCCCCCCCC
38.46-
255PhosphorylationQQSTTKASVKRPYTN
CCCCCCCCCCCCCCC
29.72-
257UbiquitinationSTTKASVKRPYTNAQ
CCCCCCCCCCCCCEE
45.20-
260PhosphorylationKASVKRPYTNAQIQI
CCCCCCCCCCEEEEE
19.3625690035
261PhosphorylationASVKRPYTNAQIQIK
CCCCCCCCCEEEEEE
27.1025690035
268SumoylationTNAQIQIKQGKDGKE
CCEEEEEEECCCCCC
36.30-
268SumoylationTNAQIQIKQGKDGKE
CCEEEEEEECCCCCC
36.3028112733
268UbiquitinationTNAQIQIKQGKDGKE
CCEEEEEEECCCCCC
36.30-
274UbiquitinationIKQGKDGKEGSVGLS
EEECCCCCCCCEEEE
69.87-
274SumoylationIKQGKDGKEGSVGLS
EEECCCCCCCCEEEE
69.87-
274SumoylationIKQGKDGKEGSVGLS
EEECCCCCCCCEEEE
69.87-
277PhosphorylationGKDGKEGSVGLSVQR
CCCCCCCCEEEEEEE
17.6920873877
281PhosphorylationKEGSVGLSVQRSVFG
CCCCEEEEEEEHHHC
15.4120873877
285PhosphorylationVGLSVQRSVFGERNF
EEEEEEEHHHCCCCE
12.52-
296PhosphorylationERNFNIHSSISHESP
CCCEECCCCCCCCCH
26.1020873877
297PhosphorylationRNFNIHSSISHESPA
CCEECCCCCCCCCHH
17.5920873877
299PhosphorylationFNIHSSISHESPAVK
EECCCCCCCCCHHHH
24.1321712546
302PhosphorylationHSSISHESPAVKLMK
CCCCCCCCHHHHHHH
16.8525159151
306UbiquitinationSHESPAVKLMKQSKT
CCCCHHHHHHHCCCH
44.99-
312UbiquitinationVKLMKQSKTVDVLSR
HHHHHCCCHHHHHHH
50.50-
318PhosphorylationSKTVDVLSRKLATKK
CCHHHHHHHHHHHHH
27.50-
331SumoylationKKKAISTKVMNSAVM
HHHHHHHHHHCHHHH
32.47-
331SumoylationKKKAISTKVMNSAVM
HHHHHHHHHHCHHHH
32.47-
331AcetylationKKKAISTKVMNSAVM
HHHHHHHHHHCHHHH
32.4730587557
331UbiquitinationKKKAISTKVMNSAVM
HHHHHHHHHHCHHHH
32.47-
340UbiquitinationMNSAVMRKTASSCPA
HCHHHHHHCCCCCCC
30.28-
348PhosphorylationTASSCPASLTCDCYA
CCCCCCCCEECCEEE
14.8919690332
356PhosphorylationLTCDCYATDKVCSIC
EECCEEECCCHHHHH
15.1819690332
358UbiquitinationCDCYATDKVCSICLS
CCEEECCCHHHHHHH
40.56-
361PhosphorylationYATDKVCSICLSRRQ
EECCCHHHHHHHCCC
21.2330631047
365PhosphorylationKVCSICLSRRQQVAP
CHHHHHHHCCCCCCC
22.4730631047
376PhosphorylationQVAPRAGTPGFRAPE
CCCCCCCCCCCCCHH
21.1810846177
386PhosphorylationFRAPEVLTKCPNQTT
CCCHHHHHCCCCCCC
35.46-
406PhosphorylationSAGVIFLSLLSGRYP
HHHHHHHHHHHCCCC
19.2628355574
415PhosphorylationLSGRYPFYKASDDLT
HHCCCCCEECCHHHH
10.92-
441UbiquitinationRETIQAAKTFGKSIL
HHHHHHHHHHCCHHH
47.61-
445AcetylationQAAKTFGKSILCSKE
HHHHHHCCHHHCCCC
30.0826051181
445UbiquitinationQAAKTFGKSILCSKE
HHHHHHCCHHHCCCC
30.08-
451UbiquitinationGKSILCSKEVPAQDL
CCHHHCCCCCCHHHH
62.83-
451AcetylationGKSILCSKEVPAQDL
CCHHHCCCCCCHHHH
62.8323749302
472PhosphorylationLRGMDSSTPKLTSDI
HCCCCCCCCCCCCCC
28.5228985074
474UbiquitinationGMDSSTPKLTSDIQG
CCCCCCCCCCCCCCC
65.57-
484PhosphorylationSDIQGHASHQPAISE
CCCCCCCCCCCCCCC
19.58-
490PhosphorylationASHQPAISEKTDHKA
CCCCCCCCCCCCCCC
34.8425159151
492UbiquitinationHQPAISEKTDHKASC
CCCCCCCCCCCCCEE
53.08-
493PhosphorylationQPAISEKTDHKASCL
CCCCCCCCCCCCEEE
39.0128555341
498PhosphorylationEKTDHKASCLVQTPP
CCCCCCCEEEEECCC
16.88-
503PhosphorylationKASCLVQTPPGQYSG
CCEEEEECCCCCCCC
24.7925159151
508PhosphorylationVQTPPGQYSGNSFKK
EECCCCCCCCCCCCC
25.1826074081
509PhosphorylationQTPPGQYSGNSFKKG
ECCCCCCCCCCCCCC
24.5025159151
512PhosphorylationPGQYSGNSFKKGDSN
CCCCCCCCCCCCCCC
41.8028985074
556PhosphorylationLLDLNPASRITAEEA
HHCCCHHHCCCHHHH
26.02-
559PhosphorylationLNPASRITAEEALLH
CCHHHCCCHHHHHHC
27.23-
570UbiquitinationALLHPFFKDMSL---
HHHCHHHHCCCC---
53.56-
573PhosphorylationHPFFKDMSL------
CHHHHCCCC------
40.85-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
216SPhosphorylationKinaseCDC7O00311
PSP
239SPhosphorylationKinaseCDC7O00311
PSP
277SPhosphorylationKinaseCDC7O00311
PSP
285SPhosphorylationKinaseCDC7O00311
PSP
296SPhosphorylationKinaseCDC7O00311
PSP
297SPhosphorylationKinaseCDC7O00311
PSP
318SPhosphorylationKinaseCDC7O00311
PSP
376TPhosphorylationKinaseCDK1P06493
PSP
376TPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CDC7_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDC7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MCM2_HUMANMCM2physical
12614612
DBF4A_HUMANDBF4physical
12614612
DBF4A_HUMANDBF4physical
10373557
ORC1_HUMANORC1physical
12614612
ORC6_HUMANORC6physical
12614612
MCM4_HUMANMCM4physical
12614612
MCM5_HUMANMCM5physical
12614612
MCM7_HUMANMCM7physical
12614612
MCM2_XENLAmcm2physical
9250678
MCM3_HUMANMCM3physical
9250678
DBF4A_HUMANDBF4physical
10523313
CAF1A_HUMANCHAF1Aphysical
16826239
MCM2_HUMANMCM2physical
16826239
MCM2_MOUSEMcm2physical
20421204
MCM4_MOUSEMcm4physical
20421204
MCM6_MOUSEMcm6physical
20421204
RAD18_HUMANRAD18physical
21098111
MCM2_HUMANMCM2physical
17927916
CDK2_HUMANCDK2physical
17927916
MCM2_HUMANMCM2physical
16446360
TOB1_HUMANTOB1physical
23066029
MCM2_HUMANMCM2physical
23066029
A4_HUMANAPPphysical
21832049
MCM2_HUMANMCM2physical
10846177
CDC7_HUMANCDC7physical
10846177
DBF4A_HUMANDBF4physical
10846177
MCM4_HUMANMCM4physical
10846177
MCM6_HUMANMCM6physical
10846177
MCM7_HUMANMCM7physical
10846177
ORC6_HUMANORC6physical
15232106
MCM10_HUMANMCM10physical
15232106
CDN1A_HUMANCDKN1Aphysical
15232106
CDN2A_HUMANCDKN2Aphysical
15232106
ARF_HUMANCDKN2Aphysical
15232106
MCM3_HUMANMCM3physical
15232106
GRHPR_HUMANGRHPRphysical
21988832
CDK9_HUMANCDK9physical
21988832
ALAT1_HUMANGPTphysical
21988832
IF122_HUMANIFT122physical
27173435
BRD4_HUMANBRD4genetic
27453043
RS11_HUMANRPS11genetic
27453043
ING5_HUMANING5genetic
27453043

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDC7_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; TYR-508 AND SER-509,AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-27, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-503, AND MASSSPECTROMETRY.

TOP